Citation Impact

Citing Papers

2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary
2014 Standout
Antithrombotic Therapy for Venous Thromboembolic Disease
2008 Standout
Regulation of renin: new evidence from cultured cells and genetically modified mice
2000
Minireview: Computer Simulations of Blood Pressure Regulation by the Renin-Angiotensin System
2003 StandoutNobel
New Antithrombotic Drugs
2008
The Impact of Continuous Positive Airway Pressure on Blood Pressure in Patients With Obstructive Sleep Apnea Syndrome
2007
New Antithrombotic Drugs
2012
Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions
2014 Standout
Penetration of Anti-Infective Agents into Pulmonary Epithelial Lining Fluid
2011
Mechanisms of NAFLD development and therapeutic strategies
2018 Standout
Deep learning methods for drug response prediction in cancer: Predominant and emerging trends
2023
Using Big Data to Discover Diagnostics and Therapeutics for Gastrointestinal and Liver Diseases
2016
Do not let death do us part: ‘find-me’ signals in communication between dying cells and the phagocytes
2016
Natriuretic peptide receptor A mediates renal sodium excretory responses to blood volume expansion
2003 StandoutNobel
Increased susceptibility to heart failure in response to volume overload in mice lacking natriuretic peptide receptor-A gene
2005 StandoutNobel
Revolutionizing healthcare: the role of artificial intelligence in clinical practice
2023 Standout
Regional Anesthesia in the Patient Receiving Antithrombotic or Thrombolytic Therapy
2009 Standout
Kidney function in mice lacking aldosterone
2005 StandoutNobel
CONSORT 2010 explanation and elaboration: Updated guidelines for reporting parallel group randomised trials
2011 Standout
International Union of Pharmacology. XLVII. Nomenclature and Structure-Function Relationships of Voltage-Gated Sodium Channels
2005 Standout
ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC)
2011 Standout
Obstructive sleep apnoea and its cardiovascular consequences
2008 Standout
Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty
2018 Standout
Otamixaban for the treatment of patients with non-ST-elevation acute coronary syndromes (SEPIA-ACS1 TIMI 42): a randomised, double-blind, active-controlled, phase 2 trial
2009
Standardized Bleeding Definitions for Cardiovascular Clinical Trials
2011 Standout
Expert panel consensus recommendations for ambulatory blood pressure monitoring in Asia: The HOPE Asia Network
2019
Physiological Implications of Hydrogen Sulfide: A Whiff Exploration That Blossomed
2012 Standout
Antithrombotic Therapy in Patients With Chronic Kidney Disease
2012
Factor Xa Inhibitors: Next-Generation Antithrombotic Agents
2010
Cu Single Atom Nanozyme Based High‐Efficiency Mild Photothermal Therapy through Cellular Metabolic Regulation
2022
Molecular Physiology of Low-Voltage-Activated T-type Calcium Channels
2003
Guidelines for the Primary Prevention of Stroke
2014 Standout
Natriuretic Peptides, Their Receptors, and Cyclic Guanosine Monophosphate-Dependent Signaling Functions
2005 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Oral Rivaroxaban for the Treatment of Symptomatic Pulmonary Embolism
2012 Standout
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
Genetic disruption of atrial natriuretic peptide receptor-A alters renin and angiotensin II levels
2001
2020 International Society of Hypertension Global Hypertension Practice Guidelines
2020 Standout
Photothermal Nanomaterials: A Powerful Light-to-Heat Converter
2023 Standout
CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials
2010 Standout
Synopsis of Some Recent Tactical Application of Bioisosteres in Drug Design
2011 Standout

Works of Markus Hinder being referenced

Pharmacokinetics of Otamixaban, a Direct Factor Xa Inhibitor, in Healthy Male Subjects: Pharmacokinetic Model Development for Phase 2/3 Simulation of Exposure
2006
Changing R&D models in research-based pharmaceutical companies
2016
Phospholipase A2 is Involved in Chemotaxis Of Human Leukocytes
1999
T‐type and L‐type calcium channel blockers exert opposite effects on renin secretion and renin gene expression in conscious rats
1998
Direct and rapid inhibition of factor Xa by otamixaban: A pharmacokinetic and pharmacodynamic investigation in patients with coronary artery disease
2006
Cardiovascular effects of mibefradil in hypertensive patients with obstructive sleep apnea
1998
Translational precision medicine: an industry perspective
2021
Role of Renal Nerves in the Stimulation of the Renin System by Reduced Renal Arterial Pressure
1999
Licogliflozin versus placebo in women with polycystic ovary syndrome: A randomized, double‐blind, phase 2 trial
2021
Effects of Sacubitril/Valsartan (LCZ696) on Natriuresis, Diuresis, Blood Pressures, and NT-proBNP in Salt-Sensitive Hypertension
2016
Use of Population Pharmacokinetic Modeling and Monte Carlo Simulation To Describe the Pharmacodynamic Profile of Cefditoren in Plasma and Epithelial Lining Fluid
2007
Rankless by CCL
2026